IP Library Granted Patent US 10,407,436
Granted Patent B2
US 10,407,436 · App. 14/734,984 · Granted Sep 10, 2019

Carboxamide-substituted xanthene dyes

Inventor: Andrei Polukhtin (Scottsdale, AZ)
C07D491/147C09K11/06C09K2211/1048C09K2211/1088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,407,436
App. No.
14/734,984
Granted
Sep 10, 2019
Kind
B2
Abstract

Carboxamide-substituted xanthene dyes, reactive dyes, and the use of such dyes as a labeling reagent are disclosed. Specifically, a carboxamide-substituted dye of the formula (I) is disclosed.

Claims (31)

1. A carboxamide-substituted dye of the formula (I)

in which:

R 1 and R 10 are hydrogen,

R 2 and R 9 are independently hydrogen or halogen,

R 5 and R 6 are independently hydrogen, SO 3 X, or SO 2 NH—(CH 2 ) n —SO 3 X, and n=2-5,

R 3 , R 4 , R 7 , and R 8 are independently H or C 1 -C 5 alkyl, where each alkyl is optionally further substituted with halogen or SO 3 X, or

R 3 in combination with R 2 form a 5- or 6-membered saturated or unsaturated ring that is optionally substituted with a C 1 -C 5 alkyl, where each alkyl is optionally further substituted with SO 3 X, or

R 8 in combination with R 9 form a 5- or 6-membered saturated ring that is optionally substituted with a C 1 -C 5 alkyl, where each alkyl is optionally further substituted with SO 3 X,

X is H or a counterion,

R 11 and R 12 are polyethylene glycol,

R 13 is N-hydroxysuccinimidyl, p-nitrophenyl, pentafluorophenyl, N-hydroxybenzotriazolyl ester, maleimido, alpha-haloacetamido, pyridyldisulfides, carbodiimide, carbonyl, diazirine, hydrazide, hydroxymethyl phosphine, imidoester, NHS-ester, PFP-ester, psoralen, pyridyl disulfide, vinyl sulfone, terminal alkyne, azide, trans-cyclooctene, or a biomolecule selected from the group consisting of a nucleic acid, a nucleotide, a protein, an amino acid, a carbohydrate monomer, or a polysaccharide, and

R 14 is hydrogen.

2. The compound according to claim 1 , wherein R 13 is a biomolecule selected from the group consisting of a protein and a nucleotide.

3. A carboxamide-substituted dye of the formula:

in which:

R 1 , R 2 , R 9 and R 10 are independently hydrogen or halogen,

R 5 and R 6 are independently hydrogen, SO 3 X, or SO 2 NH—(CH 2 ) n —SO 3 X, where X is H or a counterion, and n=2-5,

R 3 , R 4 , R 7 , and R 8 are independently H or C 1 -C 5 alkyl, where each alkyl is optionally further substituted with halogen or SO 3 X, where X is H or a counterion,

R 11 is C 1 -C 18 alkyl or a branched or cyclic saturated or unsaturated hydrocarbon group having up to 300 carbon atoms, any one of which is optionally interrupted by O or N atoms, optionally further substituted with F, Cl, Br, I, a carboxylic acid, a salt of carboxylic acid, or a carboxylic acid ester, SO 3 X, or PO 3 X, where X is H or a counterion,

R 12 is a N-hydroxysuccinimidyl, p-nitrophenyl, pentafluorophenyl, N-hydroxybenzotriazolyl ester, maleimido, alpha-haloacetamido, pyridyldisulfides, carbodiimide, carbonyl, diazirine, hydrazide, hydroxymethyl phosphine, imidoester, NHS-ester, PFP-ester, psoralen, pyridyl disulfide, vinyl sulfone, terminal alkyne, azide, trans-cyclooctene, or a biomolecule selected from the group consisting of a nucleic acid, a nucleotide, a protein, an amino acid, a carbohydrate monomer, or a polysaccharide, and

R 13 is hydrogen or halogen.

4. The compound according to claim 3 , wherein R 11 is polyethylene glycol.

5. A carboxamide-substituted dye of the formula:

in which:

R 1 , R 2 , R 3 , R 6 , R 7 , and R 8 are independently hydrogen, or C 1 -C 5 alkyl, where each alkyl is optionally further substituted with halogen or SO 3 X, where X is H or a counterion,

R 9 and R 10 are independently hydrogen, SO 3 X, or SO 2 NH—(CH 2 ) n —SO 3 X, where X is H or a counterion, and n=2-5,

R 4 and R 5 are independently hydrogen, CH 3 , or SO 3 X, where X is H or counterion,

R 11 is C 1 -C 18 alkyl or a branched or cyclic saturated or unsaturated hydrocarbon group having up to 300 carbon atoms, any one of which is optionally interrupted by 0 or N atoms, optionally further substituted with F, Cl, Br, I, a carboxylic acid, a salt of carboxylic acid, or a carboxylic acid ester, SO 3 X, or PO 3 X, where X is H or a counterion,

R 12 is a N-hydroxysuccinimidyl, p-nitrophenyl, pentafluorophenyl, N-hydroxybenzotriazolyl ester, maleimido, alpha-haloacetamido, pyridyldisulfides, carbodiimide, carbonyl, diazirine, hydrazide, hydroxymethyl phosphine, imidoester, NHS-ester, PFP-ester, psoralen, pyridyl disulfide, vinyl sulfone, terminal alkyne, azide, trans-cyclooctene, or a biomolecule selected from the group consisting of a nucleic acid, a nucleotide, a protein, an amino acid, a carbohydrate monomer, or a polysaccharide, and

R 13 is hydrogen or halogen.

6. The compound according to claim 5 , wherein R 11 is polyethylene glycol.

Assignments (2)
SECURITY INTEREST Recorded Mar 31, 2023
From: BIOCONJUGATE TECHNOLOGIES, LLC
To: AUDAX PRIVATE DEBT LLC, AS AGENT
Reel/Frame 063182/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2023
From: POLUKHTIN, ANDREI
To: BIOCONJUGATE TECHNOLOGIES, LLC
Reel/Frame 063161/0712 →
Continuity (1)
Related Publication 20160362418A1 · Dec 15, 2016